Ronald R. Tuttle
About
In The Last Decade
Ronald R. Tuttle
24 papers receiving 768 citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Cardiology and Cardiovascular Medicine 439
- Molecular Biology 181
- Surgery 176
- Radiology, Nuclear Medicine and Imaging 141
- Cellular and Molecular Neuroscience 117
Countries citing papers authored by Ronald R. Tuttle
This map shows the geographic impact of Ronald R. Tuttle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald R. Tuttle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald R. Tuttle more than expected).
Fields of papers citing papers by Ronald R. Tuttle
This network shows the impact of papers produced by Ronald R. Tuttle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald R. Tuttle. The network helps show where Ronald R. Tuttle may publish in the future.
Co-authorship network of co-authors of Ronald R. Tuttle
This figure shows the co-authorship network connecting the top 25 collaborators of Ronald R. Tuttle. A scholar is included among the top collaborators of Ronald R. Tuttle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald R. Tuttle. Ronald R. Tuttle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | Reversal of effects of morphine by nalmefene | 1 |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 8 | |
| 8 | 27 | |
| 9 | 26 | |
| 10 | 43 | |
| 11 | 2 | |
| 12 | 77 | |
| 13 | Studies on nalmefene, an opioid antagonist | 2 |
| 14 | A rapid, quantitative in vivo assay for narcotic antagonists. | 8 |
| 15 | 12 | |
| 16 | 59 | |
| 17 | 1 | |
| 18 | Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. breakdown → | 465 |
| 19 | 16 | |
| 20 | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.